vs
Side-by-side financial comparison of INSPERITY, INC. (NSP) and Organon & Co. (OGN). Click either name above to swap in a different company.
INSPERITY, INC. is the larger business by last-quarter revenue ($1.7B vs $1.5B, roughly 1.1× Organon & Co.). On growth, INSPERITY, INC. posted the faster year-over-year revenue change (3.4% vs -5.3%). INSPERITY, INC. produced more free cash flow last quarter ($246.0M vs $96.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -3.8%).
Insperity, Inc., previously known as Administaff, Inc., is a professional employer organization (PEO) headquartered in Kingwood, an area of Houston, Texas, USA. Insperity provides human resources and administrative services to small and medium-sized businesses. Since 2004, the company has been title sponsor of a professional golf tournament on the Champions Tour, previously known as the Administaff Small Business Classic.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
NSP vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $1.5B |
| Net Profit | — | $-205.0M |
| Gross Margin | 10.3% | 49.2% |
| Operating Margin | -2.8% | -9.8% |
| Net Margin | — | -13.6% |
| Revenue YoY | 3.4% | -5.3% |
| Net Profit YoY | — | -288.1% |
| EPS (diluted) | $-0.87 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.6B | ||
| Q2 25 | $1.7B | $1.6B | ||
| Q1 25 | $1.9B | $1.5B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.6B | $1.6B | ||
| Q1 24 | $1.8B | $1.6B |
| Q4 25 | — | $-205.0M | ||
| Q3 25 | $-20.0M | $160.0M | ||
| Q2 25 | $-5.0M | $145.0M | ||
| Q1 25 | $51.0M | $87.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | $3.0M | $359.0M | ||
| Q2 24 | $18.0M | $195.0M | ||
| Q1 24 | $79.0M | $201.0M |
| Q4 25 | 10.3% | 49.2% | ||
| Q3 25 | 12.0% | 53.5% | ||
| Q2 25 | 13.4% | 54.8% | ||
| Q1 25 | 16.6% | 55.6% | ||
| Q4 24 | 13.5% | 56.3% | ||
| Q3 24 | 14.7% | 58.3% | ||
| Q2 24 | 16.2% | 58.4% | ||
| Q1 24 | 19.1% | 59.0% |
| Q4 25 | -2.8% | -9.8% | ||
| Q3 25 | -1.5% | 15.2% | ||
| Q2 25 | -0.4% | 14.4% | ||
| Q1 25 | 3.7% | 6.7% | ||
| Q4 24 | -0.9% | 8.1% | ||
| Q3 24 | 0.1% | 13.1% | ||
| Q2 24 | 1.4% | 14.6% | ||
| Q1 24 | 6.0% | 14.5% |
| Q4 25 | — | -13.6% | ||
| Q3 25 | -1.2% | 10.0% | ||
| Q2 25 | -0.3% | 9.1% | ||
| Q1 25 | 2.7% | 5.8% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | 0.2% | 22.7% | ||
| Q2 24 | 1.1% | 12.1% | ||
| Q1 24 | 4.4% | 12.4% |
| Q4 25 | $-0.87 | $-0.78 | ||
| Q3 25 | $-0.53 | $0.61 | ||
| Q2 25 | $-0.14 | $0.56 | ||
| Q1 25 | $1.35 | $0.33 | ||
| Q4 24 | $-0.21 | $0.42 | ||
| Q3 24 | $0.07 | $1.38 | ||
| Q2 24 | $0.48 | $0.75 | ||
| Q1 24 | $2.08 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $682.0M | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $46.0M | $752.0M |
| Total Assets | $2.2B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $682.0M | $574.0M | ||
| Q3 25 | $521.0M | $672.0M | ||
| Q2 25 | $511.0M | $599.0M | ||
| Q1 25 | $684.0M | $547.0M | ||
| Q4 24 | $1.2B | $675.0M | ||
| Q3 24 | $596.0M | $763.0M | ||
| Q2 24 | $850.0M | $704.0M | ||
| Q1 24 | $801.0M | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $46.0M | $752.0M | ||
| Q3 25 | $87.0M | $906.0M | ||
| Q2 25 | $112.0M | $733.0M | ||
| Q1 25 | $119.0M | $542.0M | ||
| Q4 24 | $97.0M | $472.0M | ||
| Q3 24 | $125.0M | $493.0M | ||
| Q2 24 | $142.0M | $144.0M | ||
| Q1 24 | $140.0M | $48.0M |
| Q4 25 | $2.2B | $12.9B | ||
| Q3 25 | $2.0B | $13.6B | ||
| Q2 25 | $2.0B | $13.5B | ||
| Q1 25 | $2.1B | $13.2B | ||
| Q4 24 | $2.6B | $13.1B | ||
| Q3 24 | $1.9B | $12.8B | ||
| Q2 24 | $2.1B | $12.2B | ||
| Q1 24 | $2.1B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $255.0M | $141.0M |
| Free Cash FlowOCF − Capex | $246.0M | $96.0M |
| FCF MarginFCF / Revenue | 14.7% | 6.4% |
| Capex IntensityCapex / Revenue | 0.5% | 3.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-309.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $255.0M | $141.0M | ||
| Q3 25 | $-11.0M | $264.0M | ||
| Q2 25 | $-79.0M | $220.0M | ||
| Q1 25 | $-443.0M | $75.0M | ||
| Q4 24 | $619.0M | $390.0M | ||
| Q3 24 | $-150.0M | $141.0M | ||
| Q2 24 | $20.0M | $332.0M | ||
| Q1 24 | $31.0M | $76.0M |
| Q4 25 | $246.0M | $96.0M | ||
| Q3 25 | $-20.0M | $218.0M | ||
| Q2 25 | $-86.0M | $181.0M | ||
| Q1 25 | $-449.0M | $43.0M | ||
| Q4 24 | $606.0M | $335.0M | ||
| Q3 24 | $-164.0M | $99.0M | ||
| Q2 24 | $14.0M | $300.0M | ||
| Q1 24 | $26.0M | $30.0M |
| Q4 25 | 14.7% | 6.4% | ||
| Q3 25 | -1.2% | 13.6% | ||
| Q2 25 | -5.2% | 11.4% | ||
| Q1 25 | -24.1% | 2.8% | ||
| Q4 24 | 37.6% | 21.0% | ||
| Q3 24 | -10.5% | 6.3% | ||
| Q2 24 | 0.9% | 18.7% | ||
| Q1 24 | 1.4% | 1.8% |
| Q4 25 | 0.5% | 3.0% | ||
| Q3 25 | 0.6% | 2.9% | ||
| Q2 25 | 0.4% | 2.4% | ||
| Q1 25 | 0.3% | 2.1% | ||
| Q4 24 | 0.8% | 3.5% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 0.4% | 2.0% | ||
| Q1 24 | 0.3% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | — | 1.52× | ||
| Q1 25 | -8.69× | 0.86× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | -50.00× | 0.39× | ||
| Q2 24 | 1.11× | 1.70× | ||
| Q1 24 | 0.39× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSP
| Northeast | $455.0M | 27% |
| West | $339.0M | 20% |
| Southwest | $317.0M | 19% |
| Central | $299.0M | 18% |
| Southeast | $241.0M | 14% |
| Other Revenues | $17.0M | 1% |
OGN
Segment breakdown not available.
